Ageing with HIV: medication use and risk for potential drug-drug interactions
about
Managing drug interactions in HIV-infected adults with comorbid illnessComorbidities among the HIV-infected patients aged 40 years or older in TaiwanPolypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infectionPolypharmacy in the HIV-infected older adult population.Changes in first-line cART regimens and short-term clinical outcome between 1996 and 2010 in The NetherlandsThe evolution of three decades of antiretroviral therapy: challenges, triumphs and the promise of the future.Cardiovascular disease risk in an aging HIV population: not just a question of biology.Increased mortality after a first myocardial infarction in human immunodeficiency virus-infected patients; a nested cohort study.Role of the Pharmacist in Caring for Patients with HIV/AIDS: Clinical Practice Guidelines.Potential drug-drug interactions among elderly patients admitted to medical ward of Ayder Referral Hospital, Northern Ethiopia: a cross sectional study.Clinical pharmacokinetics of antiretroviral drugs in older persons.Triple-combination rilpivirine, emtricitabine, and tenofovir (Complera™/Eviplera™) in the treatment of HIV infection.The next therapeutic challenge in HIV: polypharmacy.Polypharmacy and risk of antiretroviral drug interactions among the aging HIV-infected population.Polypharmacy in older adults with human immunodeficiency virus infection compared with the general population.Potential drug interactions in patients given antiretroviral therapy.Age, time living with diagnosed HIV infection, and self-rated health.Pharmacological management of cardiovascular conditions and diabetes in older adults with HIV infection.Use of non-antiretroviral drugs among individuals with and without HIV-infection: a Danish nationwide study.Ageing with HIV: a multidisciplinary review.Immunosenescence and hurdles in the clinical management of older HIV-patients.Physiologically Based Pharmacokinetic Modeling to Predict Drug-Drug Interactions with Efavirenz Involving Simultaneous Inducing and Inhibitory Effects on Cytochromes.Premature and accelerated aging: HIV or HAART?HIV-infected patients' beliefs about their chronic co-treatments in comparison with their combined antiretroviral therapy.Comparing the Frequencies of Contraindicated Drug-Drug Interactions Between Differing Antiretroviral Regimens in HIV-Infected Patients.Graying of the HIV epidemic: a challenge for inpatient medicine providers.Prevalence of concomitant medications in older HIV+ patients and comparison with general population.Clinical characteristics and antiretroviral treatment of older HIV-infected patients.A review of drug-drug interactions in older HIV-infected patients.Increased costs of HIV care associated with aging in an HIV-infected population.Frequency of electrocardiogram testing among HIV-infected patients at risk for medication-induced QTc prolongation.The clinical utility of HIV outpatient pharmacist prescreening to reduce medication error and assess adherence.Association of age with polypharmacy and risk of drug interactions with antiretroviral medications in HIV-positive patients.Frequency and severity of potential drug interactions in a cohort of HIV-infected patients Identified through a Multidisciplinary team.Non antiretroviral polypharmacy and adverse health outcomes among HIV-infected and uninfected individuals.Aging in HIV-Infected Subjects: A New Scenario and a New View.Polypharmacy among HIV positive older adults on anti-retroviral therapy attending an urban clinic in Uganda.Comorbidities and the use of comedications in people living with HIV on antiretroviral therapy in Japan: a cross-sectional study using a hospital claims database.British HIV Association guidelines for the treatment of HIV-1-positive adults with antiretroviral therapy 2015Physiologically based pharmacokinetic models for the optimization of antiretroviral therapy: recent progress and future perspective
P2860
Q26825406-5CDE79EF-74DE-4694-992D-24B889F3A6C1Q28541867-03D7C2BC-33FE-4E95-B8B2-7930C061D7A1Q33705770-954E42B5-09F9-4AB3-BF71-30C2BECCCCDFQ34037407-288661B8-0314-4496-B486-2A13B5798F6FQ35010207-CF75DCAF-FFCD-4B9D-A968-5C791C09F688Q35023687-512DC7BE-A295-4FAA-856E-C524782762B3Q35064091-78A975A5-F5F2-41F6-B108-1F80336590F4Q35107777-D359E583-7373-46EF-B1B0-8EAF5D603E1FQ35898538-DAB6CE45-BDD4-4CDD-A2F8-85279AD7C14EQ36120277-A85713EE-70C0-4063-9277-BF60D7883752Q36905884-3CE2C786-94BC-43E0-945D-F535E11BC407Q36958229-0758E53D-91A2-4B26-BC7E-AAC916EA0FFDQ37025385-63994337-185F-4227-B341-619EEF1CCB1DQ37203653-8AD5438F-4963-42A8-9673-AA3F2337CFACQ37225786-5FBF2CE0-7C44-4DDA-AD3A-04F5779683F8Q37520779-79C94BD1-D083-4262-B2D6-2BB697332D61Q37594183-4CFDF290-B250-4300-AE45-8D7CF50F3E95Q38172305-D1E9C662-8F57-4E0B-AF3F-46A51CEF52ABQ38405463-F932AEF1-D9E7-441E-9E86-679E013F0E05Q38490362-9BDD728C-9CC4-4F29-B289-A1568E2DCCECQ39170367-33E08825-4276-45F8-A4CF-0EA290224014Q39418438-03D2B7BD-B6D7-42E2-90A2-4DFC37812449Q39474417-5BCDDEBD-FB5A-4A0F-8CDF-DAF531E60BBFQ40090353-F835238D-12B3-4049-B407-3FE4B72B9788Q40262860-960C4F6A-AF74-4947-B155-66043E2A640FQ40876796-A74BD8AF-44F9-449C-97CC-01519A37B22EQ41228179-7CE3121A-4FA8-4AD9-AAC6-6BE4E7E88DCAQ41727026-4AF54482-7CB4-40AC-836E-4243B87B03CCQ41996857-AD51F198-81A2-4A6F-A38D-3B4F400272B2Q42202635-7C0A3136-D278-4B74-A272-B2696C19CA1AQ42990255-92436C44-F571-4B47-AC58-F171BCBCD645Q44273051-9B23494B-93F2-4B28-AE56-AB4571266AEDQ46143194-3A57D791-7CD6-42A2-95EC-627156768448Q47407447-27B1A0CA-AA77-42A9-A40C-3898CD4076ECQ47646675-483AAEC1-8D7D-4616-A92B-8C24E2FAB894Q50072732-5776A4F0-7799-436A-92F1-2A4187219D88Q55235138-C12ED7C9-9592-4112-AEB2-8378E215E453Q55406947-492480BD-6EF3-471B-88C8-033CB3B3038FQ57180790-291DB894-1CAF-4A35-8C91-C09D1CD49209Q58073610-7FCF263E-D561-45D4-BD52-21B6F2C19985
P2860
Ageing with HIV: medication use and risk for potential drug-drug interactions
description
article
@en
im Juni 2011 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в червні 2011
@uk
ലേഖനം
@ml
name
Ageing with HIV: medication use and risk for potential drug-drug interactions
@en
Ageing with HIV: medication use and risk for potential drug-drug interactions
@nl
type
label
Ageing with HIV: medication use and risk for potential drug-drug interactions
@en
Ageing with HIV: medication use and risk for potential drug-drug interactions
@nl
prefLabel
Ageing with HIV: medication use and risk for potential drug-drug interactions
@en
Ageing with HIV: medication use and risk for potential drug-drug interactions
@nl
P2093
P2860
P356
P1476
Ageing with HIV: medication use and risk for potential drug-drug interactions
@en
P2093
A. Fontana
A. Telenti
B. Hirschel
B. Ledergerber
B. Martinez
C. Kahlert
P2860
P304
P356
10.1093/JAC/DKR248
P407
P577
2011-06-16T00:00:00Z